Re: Genomic Differences between "Primary" and "Secondary" Muscle-Invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-Based Neoadjuvant Chemotherapy
J Urol. 2019 Jul;202(1):30.
doi: 10.1097/01.JU.0000557728.16853.8f.
Epub 2019 Jun 7.